drugset / Trial / NCT07424625

A Study of Tris-Hydroxymethyl Aminomethane (THAM) Versus Sodium Bicarbonate in Cardiac Surgical Patients

NCT07424625 ↗

Phase 4 Recruiting 250 enrolled Mayo Clinic
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this research is to determine if two commonly used medications to treat metabolic acidosis in the setting of cardiac surgery, sodium bicarbonate and THAM, are equivalent.

Timeline

Start
2026-09-14
Primary completion
2027-12
Completion
2028-06

Drugs

EvaluationDrugModalityDoseRoute
Subject TROMETHAMINE Small molecule 500 ml —
Comparator sodium bicarbonate Diagnostic / imaging agent 100 meq —

Indications